Taking the uncertainty out of diagnosis for hereditary disorders will allow you to focus on early intervention.

Research reported by the U.S. Centers for Disease Control & Prevention in May 2011, states that one in 6 children are born with some form of developmental disability such as autism, learning disorders or ADHD.

Early and accurate detection of these disorders can help medical professionals direct their attention to constructive intervention with appropriate treatment and management protocols.

Now, through Sengenics, doctors can access the most accurate and reliable genetic diagnostic tool right here in Asia. The Sengenics test, using the latest microarray Comparative Genomics Hybridisation (aCGH) platform, is able to analyze the whole genome with far greater accuracy and sensitivity over a broader spectrum than any of the conventional tests currently available such as FISH, PCR and Karyotyping, or even other newer microarray platforms. This allows for a precise and objective diagnosis of genetic disorders at the earliest stage, even before any symptoms have manifested.

The Sengenics Test was developed at Oxford University by Professor Ed Southern, the originator of microarray technology and founder of Oxford Gene Technology (OGT), considered one of the leading genomics companies in the world.

Sengenics has an exclusive strategic partnership with OGT to develop genetic laboratories in Asia and the Middle East utilizing the aCGH platform. This will allow a much faster turn-around time of less than 4 weeks from receipt of sample to presentation of full diagnostic report.

This particular microarray platform was examined together with other microarrays by leading medical institutions and was the only one selected for diagnostics, based on its most accurate, sensitive and reproducible results. It is now the first-tier diagnostic choice for 27 leading institutions around the world, including the National Health Service in the UK, Harvard Medical School, Emory Genetics and Sick Kids' Hospital in Toronto.

In keeping with Sengenics' mission to go "Beyond the Diagnostics", we will support medical professionals by connecting them to our worldwide network of information and counselling resources.